The classification results above suggest that IL-1α, IL-6 and IL-8 may be broadly applicable as ME/CFS illness markers but that their contribution should be adjusted based on duration of illness and perhaps other related covariate factors. The gene discussed is IL6; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.